| abstract |
The invention discloses a mouthwash for treating oral ulcers after chemotherapy and radiotherapy in the field of medical technology, and aims to solve the problem in the prior art that patients with malignant tumors are prone to oral ulcers after radiotherapy and chemotherapy, resulting in inability to eat. 100ml of normal saline includes the following components, recombinant human granulocyte macrophage stimulating factor for injection 100-200ug, vitamin C injection 0.5-1g, vitamin B6 injection 0.1-0.3g, and dexamethasone sodium phosphate injection 3-8mg , lidocaine hydrochloride 50‑150mg. The present invention provides an effective mouthwash solution with mucosal repair function for application after chemotherapy, which can effectively solve the oral ulcer caused by radiotherapy and chemotherapy of malignant tumor, increase the nutritional intake of malignant tumor patients during treatment and improve the patient's health Quality of Life. |